Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Cancers
|
September 28, 2021
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond
Irene Strassl, Martin Schreder, Normann Steiner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2016
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)
Michael A Fridrik, Ulrich Jaeger, Andreas Petzer, et al.
Wiener Klinische Wochenschrift
|
November 20, 2020
Austrian recommendations for the management of essential thrombocythemia
Veronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, et al.
Wiener Klinische Wochenschrift
|
December 15, 2016
Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
Thamer Sliwa, Christine Beham-Schmid, Sonja Burgstaller, et al.
Wiener Klinische Wochenschrift
|
January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
Peter Valent, Thomas Lion, Dominik Wolf, et al.
Wiener Klinische Wochenschrift
|
July 21, 2018
Austrian recommendations for the management of polycythemia vera
Sonja Burgstaller, Veronika Buxhofer-Ausch, Thamer Sliwa, et al.
Therapeutic Advances in Medical Oncology
|
October 25, 2021
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Scientific Reports
|
September 18, 2023
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, et al.
Wiener Klinische Wochenschrift
|
July 26, 2018
Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management
Maria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
August 31, 2017
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, et al.
Cancers
|
September 28, 2021
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond
Irene Strassl, Martin Schreder, Normann Steiner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2016
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)
Michael A Fridrik, Ulrich Jaeger, Andreas Petzer, et al.
Wiener Klinische Wochenschrift
|
November 20, 2020
Austrian recommendations for the management of essential thrombocythemia
Veronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, et al.
Wiener Klinische Wochenschrift
|
December 15, 2016
Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement
Thamer Sliwa, Christine Beham-Schmid, Sonja Burgstaller, et al.
Wiener Klinische Wochenschrift
|
January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
Peter Valent, Thomas Lion, Dominik Wolf, et al.
Wiener Klinische Wochenschrift
|
July 21, 2018
Austrian recommendations for the management of polycythemia vera
Sonja Burgstaller, Veronika Buxhofer-Ausch, Thamer Sliwa, et al.
Therapeutic Advances in Medical Oncology
|
October 25, 2021
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Scientific Reports
|
September 18, 2023
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
Bernhard Doleschal, Hossein Taghizadeh, Gerald Webersinke, et al.
Wiener Klinische Wochenschrift
|
July 26, 2018
Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management
Maria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, et al.
Page
of 7